Heparin binding induces conformational changes in Adeno-associated virus serotype 2. - Test2 - elhamkhani - TriplyDB

Heparin binding induces conformational changes in Adeno-associated virus serotype 2.

Heparin binding induces conformational changes in Adeno-associated virus serotype 2.

http://www.wikidata.org/entity/Q41572340

about

Human bocavirus capsid structure: insights into the structural repertoire of the parvoviridae Adeno-associated Virus as a Mammalian DNA Vector Role of capsid proteins in parvoviruses infection Parvovirus glycan interactions The structure of adeno-associated virus serotype 3B (AAV-3B): Insights into receptor binding and immune evasion Structural Characterization of the Dual Glycan Binding Adeno-Associated Virus Serotype 6 Structural Studies of Adeno-Associated Virus Serotype 8 Capsid Transitions Associated with Endosomal Trafficking Structural Insights into Adeno-Associated Virus Serotype 5 Electron microscopy analysis of a disaccharide analog complex reveals receptor interactions of adeno-associated virus The structure of AAVrh32.33, a novel gene delivery vector Comparative analysis of adeno-associated virus capsid stability and dynamics Reengineered AAV vectors: old dog, new tricks.The 2.8 Å Electron Microscopy Structure of Adeno-Associated Virus-DJ Bound by a Heparinoid Pentasaccharide.Tunable protease-activatable virus nanonodes Engineering liver-detargeted AAV9 vectors for cardiac and musculoskeletal gene transfer.Reengineering a receptor footprint of adeno-associated virus enables selective and systemic gene transfer to muscle.Directed evolution of adeno-associated virus for enhanced gene delivery and gene targeting in human pluripotent stem cells.Synthetic virology: engineering viruses for gene delivery The globoside receptor triggers structural changes in the B19 virus capsid that facilitate virus internalization Random Insertion of mCherry Into VP3 Domain of Adeno-associated Virus Yields Fluorescent Capsids With no Loss of Infectivity.Multiple roles for sialylated glycans in determining the cardiopulmonary tropism of adeno-associated virus 4 Functional analysis of the putative integrin recognition motif on adeno-associated virus 9.Identification of the heparin binding site on adeno-associated virus serotype 3B (AAV-3B).Intracellular transport of recombinant adeno-associated virus vectors.High-efficiency transduction of human monocyte-derived dendritic cells by capsid-modified recombinant AAV2 vectors.The threefold protrusions of adeno-associated virus type 8 are involved in cell surface targeting as well as postattachment processing.Identification of the galactose binding domain of the adeno-associated virus serotype 9 capsid MRI roadmap-guided transendocardial delivery of exon-skipping recombinant adeno-associated virus restores dystrophin expression in a canine model of Duchenne muscular dystrophy.Glycan binding avidity determines the systemic fate of adeno-associated virus type 9.Strategies to circumvent humoral immunity to adeno-associated viral vectors.Perspective on Adeno-Associated Virus Capsid Modification for Duchenne Muscular Dystrophy Gene Therapy Heparin increases the infectivity of Human Papillomavirus type 16 independent of cell surface proteoglycans and induces L1 epitope exposure Impact of Heparan Sulfate Binding on Transduction of Retina by Recombinant Adeno-Associated Virus Vectors Capsid antibodies to different adeno-associated virus serotypes bind common regions.Engraftment of a galactose receptor footprint onto adeno-associated viral capsids improves transduction efficiency.Heparin-binding correlates with increased efficiency of AAV1- and AAV6-mediated transduction of striated muscle, but negatively impacts CNS transduction Virus-like particles in vaccine development.Adeno-associated virus structural biology as a tool in vector development.Characterization of the Adeno-Associated Virus 1 and 6 Sialic Acid Binding Site Cryo-electron Microscopy Reconstruction and Stability Studies of the Wild Type and the R432A Variant of Adeno-associated Virus Type 2 Reveal that Capsid Structural Stability Is a Major Factor in Genome Packaging.

P2860

Q24606666-6FAB70CB-4732-40D5-B1E2-DA46D284EE4C Q26782605-D0E4E5A2-3841-4F91-A2E8-D3D9E3660FDB Q26799552-0EF25455-1036-46B8-AB0D-E840C72CD360 Q26858992-FED0FD3B-33C1-419D-A83D-5A6924D5704A Q27661320-F11B0B30-9B08-4E9E-A848-68A18B12D478 Q27664641-C656EBCA-1FD9-47FB-A648-488D62979170 Q27673394-E8249E79-0619-4099-9275-C8BAA687F430 Q27679454-0E534712-EA64-4CD7-95F1-154137D5E458 Q27679952-83E28A25-B417-4192-AEE1-46DD30AF4672 Q27682946-536A1119-A246-4DA4-8EF2-DEEAA09C5F6C Q30557598-6B6AD062-8F69-4A89-8E6A-9EC671888029 Q33591886-5ACAAAE8-0528-46E3-9455-974A1C2EC4E5 Q33633258-95EC6807-D019-493A-95C3-77137E9C410C Q33716080-EF7AD5EB-5E0C-4BC2-AECA-D3C8F6452E11 Q33833473-96CCEBEF-047D-43C3-B3A9-79AB321BC429 Q34028528-BDE0F739-7E99-43B0-AC48-3CC934F6447C Q34080512-28A78A88-D8C0-44A6-88A1-41BD1C3A633D Q34487264-2C541FE8-64D7-4A0E-991C-C731399F172E Q34623255-0BFCF556-C2C1-4D60-87AC-2AD32F6A2D42 Q34694806-AD7F7170-610D-46C5-8205-0D9C427A408A Q34997974-C8C71E5B-BE5A-4651-9889-30F077C0B0DA Q35121258-0F036D01-4D5E-420B-96EC-F2C5D7042F74 Q35661179-0B4F5D8D-81BC-44F8-AC40-E012B7797E6C Q35734826-4EF60311-125B-4DD5-AEC2-853B39D05452 Q35973549-9E4FA42E-C105-4B83-97B2-192484D37631 Q36155013-72695ABF-FE7E-46C8-9BFC-723C7AEA48EA Q36155479-99ED0B13-4DD8-4150-AE8B-B151C8F5F2BB Q36179776-21392C91-7391-4037-8992-203B97C4E7CA Q36276561-207E3990-6B57-4F76-B3C1-776C0C0B4F70 Q36398678-EB1268D1-9178-4C54-B291-193FF00F7DD8 Q36406869-1E53A25E-4669-49F4-859D-AB2F9C88449B Q36517471-DEB5677B-8AD4-4434-A587-D589995926AD Q36736418-E1A36C08-25D1-4FB1-9104-A7BAFFAEC05C Q37123344-415AAC06-4A0D-477A-9279-62993560322A Q37213826-47DBDE14-6D82-486C-BCCE-29CCCF57CA92 Q37731803-D721CF3E-013A-41E5-9D18-16DE3E917BD1 Q37798008-4C9CD87E-47E0-44F4-BD5C-84A163AA74B4 Q38188560-495BD02E-364C-4AB5-8161-F79B98E92E53 Q38787435-65AAF469-7D93-4311-8FC2-77FAFBC63856 Q39578007-E17B1F2D-DA45-46C2-922B-5B907DD99CD5

P2860

Heparin binding induces conformational changes in Adeno-associated virus serotype 2.

http://www.wikidata.org/entity/Q41572340

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Heparin binding induces conformational changes in Adeno-associated virus serotype 2.

@en

type

label

Heparin binding induces conformational changes in Adeno-associated virus serotype 2.

@en

prefLabel

Heparin binding induces conformational changes in Adeno-associated virus serotype 2.

@en

P1433

Q41572340-8EF0F261-B750-4979-B5D7-2DDD43A54129

P1476

Q41572340-6C7DD051-DBEE-4B83-B9DF-1DC8FD93FDE7

P2093

Q41572340-1CBA5F1C-8FC7-474E-8A0A-388BFE700047

Q41572340-438D2A4B-C5EE-4518-9E38-23404F960E68

Q41572340-5E11D69F-DED2-438B-B415-6D1BDC4727E1

Q41572340-663F47BD-7F95-4B86-9A64-EF0FDE7981AE

Q41572340-7C331728-66AF-4B00-9A9F-F7781AE1540A

Q41572340-94121A8D-6CFE-419A-B9B0-962D02748A9D

Q41572340-96A7ED68-AFDC-4BED-976A-7A0331366286

Q41572340-B98C69DD-12B9-4365-8238-7BBF1090EC8C

Q41572340-DF0C1136-7EE2-4422-AF80-F9256BFF8B60

Q41572340-F9FD315A-F2E8-4A31-960B-3205FCB460C8

P2860

Q41572340-005D403E-0165-4ABF-8228-538D8B97D6A9

Q41572340-10D35D46-3932-41AA-BF21-A075493AE1C5

Q41572340-19B8EF2C-DE7E-41D1-8514-3333CFE75595

Q41572340-1A9C809D-002D-4360-AF41-243048FB4F72

Q41572340-1E41D615-41C5-40BF-AE13-4D8FBEB9F6BB

Q41572340-28468BBB-C15C-4FD9-9DBA-A7EAD0D41813

Q41572340-2A75C06D-2E65-4ACD-9656-22F289EADB8B

Q41572340-2B1E662E-FF52-4B87-BC70-F6AF0F43A577

Q41572340-2EA5E407-10C2-425C-9F23-2E134AA4AF49

Q41572340-31963F8A-ABF8-430E-9BCF-709C57193C6C

P304

Q41572340-ADE260C7-3F88-4976-83A1-C6E6FBAAD858

P31

Q41572340-DD8CA144-4025-4D97-BF50-CB845E6547A9

P356

Q41572340-A4B8A4AA-8760-4A04-AFB8-049947426817

P433

Q41572340-3A0A098A-9E0B-4118-BF1C-8AD4CC9F0278

P478

Q41572340-CA4AD214-C2BD-405E-B9AC-DEF3CEA4AE18

P50

Q41572340-A4DDCE64-801D-42CE-9947-331584D2A686

P577

Q41572340-F71D90B1-5062-4147-9D39-72E1229EC398

P5875

Q41572340-89DDA704-BF87-483F-8A1C-91C2E26311F2

P698

Q41572340-FA401816-C944-441D-802C-231A4B24AE5D

P932

Q41572340-186BEB26-E0B1-4FCD-8206-ADFF49B3D13C

P356

J.JSB.2008.12.002

P1433

Journal of Structural Biology

P1476

Heparin binding induces conformational changes in Adeno-associated virus serotype 2.

@en

P2093

Hazel C Levy

http://www.w3.org/2001/XMLSchema#string

Kenneth Warrington

http://www.w3.org/2001/XMLSchema#string

Kevin Nash

http://www.w3.org/2001/XMLSchema#string

Lakshmanan Govindasamy

http://www.w3.org/2001/XMLSchema#string

Nicholas Muzyczka

http://www.w3.org/2001/XMLSchema#string

Robert McKenna

http://www.w3.org/2001/XMLSchema#string

Timothy S Baker

http://www.w3.org/2001/XMLSchema#string

Valorie D Bowman

http://www.w3.org/2001/XMLSchema#string

Weijun Chen

http://www.w3.org/2001/XMLSchema#string

Xiaodong Yan

http://www.w3.org/2001/XMLSchema#string

P2860

Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism.

Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions

The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy.

Evidence for packaging of rep-cap sequences into adeno-associated virus (AAV) type 2 capsids in the absence of inverted terminal repeats: a model for generation of rep-positive AAV particles.

Safety and efficacy of gene transfer for Leber's congenital amaurosis

Asymmetric binding of transferrin receptor to parvovirus capsids

Improved methods for building protein models in electron density maps and the location of errors in these models

The structure of pariacoto virus reveals a dodecahedral cage of duplex RNA

Structures of Host Range-Controlling Regions of the Capsids of Canine and Feline Parvoviruses and Mutants

Structure of Adeno-Associated Virus Serotype 8, a Gene Therapy Vector

P304

146-156

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JSB.2008.12.002

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

165

http://www.w3.org/2001/XMLSchema#string

P50

Mavis Agbandje-McKenna

P577

2008-12-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23719111

http://www.w3.org/2001/XMLSchema#string

P698

19121398

http://www.w3.org/2001/XMLSchema#string

P932

3694330

http://www.w3.org/2001/XMLSchema#string